Neuropsychiatric symptoms in a patient under cystic fibrosis transmembrane conductance regulator modulators treatment: a case report

aBipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona

bInstitut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona

cPsychiatry Department, Hospital Naval, Complexo Universitario de Ferrol (CHUF), Ferrol, A Coruña

dNeurology Department, Institute of Neuroscience, Hospital Clínic, University of Barcelona, CIBERNED, IDIBAPS, Barcelona, Catalonia

eDepartment of Anaesthesiology, Hospital Clínic de Barcelona, Barcelona

fBiomedical Research Networking Center for Mental Health Network (CIBERSAM), Instituto Carlos III, Madrid, Spain

Received 8 November 2022 Accepted 20 March 2023.

*Helena Andreu and Luis Olivier are joint first authors.

Correspondence to Isabella Pacchiarotti, MD, PhD, Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, c. Villarroel, 170, 08036 Barcelona, Spain, Tel: +3493227540; e-mail: [email protected]

留言 (0)

沒有登入
gif